FDA Expands Phytosterol Heart Health Claim In Proposed Rule
This article was originally published in The Tan Sheet
Executive Summary
FDA significantly overhauls a health claim linking phytosterols to a reduced risk of coronary heart disease, expanding the type of enriched conventional foods and forms of dietary supplements that can make the claim.
You may also be interested in...
FDA Extends Enforcement Discretion On Free Phytosterol Health Claims
FDA will give firms a year to relabel or reformulate dietary supplements with nonesterified phytosterols to comply with a proposed rule that overhauls a health claim linking phytosterols to a reduced risk of coronary heart disease.
Limit On Phytosterol CHD Health Claim Would Disrupt Industry – Cargill
Dietary supplement industry stakeholders "urgently" ask FDA to continue allowing coronary heart disease reduction health claims for supplements with nonesterified phytosterols, or risk "irreparable injury" to some firms.
Dannon's FTC Settlement Requires FDA Approval For Cold/Flu Immunity Claims
The Dannon Co. will drop "exaggerated" health claims for two yogurt products, including claims in advertising with actress Jamie Lee Curtis, under a settlement with the Federal Trade Commission.